| Literature DB >> 33576511 |
Abstract
"Maskne" is a new term coined during the 2020 COVID-19 pandemic. It refers to a subset of acne mechanica, deserving consideration in view of widespread reusable fabric mask-wearing to control the pandemic worldwide. Understanding of underlying pathophysiology directly relates to the novel skin microenvironment and textile-skin friction created by mask-wearing, distinct from nontextile-related acne mechanica previously linked to wearing of headgear. Specifically, the occlusive microenvironment leads to microbiome dysbiosis, which is linked to various dermatological conditions. Additional textile-skin interactions include factors such as breathability, stickiness sensations, moisture saturation, and hygiene maintenance. Increased skin temperatures can trigger sweat/heat-related dermatoses, and ear loops potentially trigger pressure-induced dermatoses. Important therapeutic considerations include increased skin irritation potential of conventional acne treatments under occlusion, exacerbation of chronic dermatoses, that is, perioral dermatitis, rosacea, and eczema, and susceptibility of these same patient groups to heightened discomfort with mask-wearing. Cotton, as the traditional fabric of choice for dermatology patients, has limited benefits in the context of face masks - increased subjective discomfort relates to increased moisture saturation and stickiness, inevitable because of high biofluid load of the nasal and oral orifices. Prolonged textile-skin contact time, directly proportional to the risk of maskne, can be an opportunity for the application of biofunctional textiles.Entities:
Mesh:
Year: 2021 PMID: 33576511 PMCID: PMC8013758 DOI: 10.1111/ijd.15425
Source DB: PubMed Journal: Int J Dermatol ISSN: 0011-9059 Impact factor: 3.204
Figure 1Proposed method of mask handling when eating/drinking/exercising. (a) The fabric face mask for public use should cover the nose and the mouth when worn, for protection of the environment from biofluid contamination. (b) When eating/drinking/exercising, the mask can be conveniently looped under the jawline which forms a natural hold for storage, minimizing the risk of further contamination and enabling quick re‐wearing. (c) Dangling a mask off one side of face while performing said activities is not recommended as it exposes biofluid for potential contamination of the environment
Review of in vitro and in vivo studies involving biofunctional textiles with antimicrobial properties
| Reference | Material | Effect | |
|---|---|---|---|
| Textiles modified by Zn compounds | |||
|
| |||
| Pandimurugan | ZnO NPs/cotton | Inhibits | |
| Ghasemi | ZnO NPs/cotton | Inhibits | |
| Khan | ZnO NPs/cotton | Inhibits | |
| D'Agua | ZnO NPs/cotton | Inhibits MRSA, | |
| Shaheen | ZnO NPs/cotton | Inhibits | |
| Souza | ZnO NPs/cotton | Inhibits | |
| Ran | ZnO NPs/cotton | Inhibits | |
| Salat | ZnO NPs/cellulose | Inhibits | |
| Wang | ZnO NPs/cotton | Inhibits | |
| Petkova | ZnO NPs/cotton | Inhibits | |
| El‐Nahhal | ZnO NPs/cotton | Increases antimicrobial activity toward | |
| Das | ZnO NPs/cotton | Inhibition of | |
| Kar | ZnO NPs/cotton Khadi | Inhibits | |
| Huang | ZnO NPs/silk | Has UPF >50 | |
| Nourbakhsh | ZnO NPs/polyester | Inhibits | |
| Ashraf | ZnO NPs/polyester, cotton | Inhibits | |
| Paul | ZnSnO3/cotton | Inhibits Gram‐positive and Gram‐negative bacteria with UPF 45 | |
| Amani | ZnO NPs/polyester | Inhibits | |
| Preethi | ZnO NPs/cotton | Inhibits | |
| Fiedot‐Tobola | ZnO microparticles/polyethylene terephthalate, polyamide, polypropylene | Inhibits | |
| Hassabo | Ag NPs/ZnO NPs/Cu NPs/cotton | Durable antibacterial and UV protection properties. | |
| Holt | ZnCl2/polyester | Inhibits | |
|
| |||
| Wollina | Smartcel sensitive (ZnO NPs/cotton, lyocell, elastane) | Sleep improvement and pruritus alleviation was observed in neurodermatitis patients after 10 days | |
| Hoefer | Smartcel sensitive (ZnO NPs/cotton, lyocell, elastane); Benevit Zinc+ (lyocell, ZnO NPs/Smartcel sensitive, spandex); DermaSilk (AEGIS 5772/silk); Padycare (polyamide, Ag NPs/lycra); Binamed (modal, Ag NP/polyester, lycra) | ZnO‐containing fabrics have stronger antibacterial activity than Ag‐containing samples, which are more effective in decreasing lesion severity, while silk fabrics alleviate pruritus and symptoms | |
| Wiegand | Benevit Zink+ (lyocell, ZnO NPs/Smartcel sensitive, spandex) | Improved night sleep, pruritus, and AD severity | |
| Textiles modified by Cu compounds | |||
|
| |||
| Teli | Cu NPs/bamboo rayon | Inhibits | |
| Hammer | Cu NPs/cotton | Inhibits | |
| Sharma P | Cu NPs/cotton | Inhibits | |
| Turalija | Cu2O microparticles/polyester | Inhibits | |
| Bhutiya PL | Cu2O NPs/cellulose | Inhibits | |
| Vasantharaj S | CuO NPs/cotton | Inhibits | |
| Galani | Cu NPs/para‐aramide and polyester | Inhibits | |
| Sójka‐Ledakowicz | CuSiO3/polypropylene and polylactide | Inhibits | |
| Imai K | Cu2+/cotton | Inactivates avian influenza virus H5 subtype | |
|
| |||
| Marcus | CuO NPs/linen, cotton and polyester | Reductions of 29.3, 55.5, 23.0, and 27.5% in the ATIEs, fever days, days of antibiotic treatment, and antibiotics. | |
| Butler (2018) | CuO NPs/linen, cotton and polyester | ~48% reductions in HCAI caused by | |
| Lazary | CuO NPs/linen, cotton and polyester | A 24% reduction in HCAI, a 47% reduction in number of fever days and a 32.8% reduction in total number of days of antibiotic administration | |
| Dykes (2015) | CuO NPs/polyester | After 4 weeks, an increase in the mean net skin and biological elasticity of 31.4 and 20.7%, respectively, was observed | |
| Gargiulio | CuO NPs/polyester | Amelioration of tinea pedis | |
| Baek | CuO NPs/polyester | Decrease of crow's feet was observed after 4 weeks | |
| Borkow | CuO NPs/polyester | Reduction of facial wrinkles and crow's feet/fine lines after 2 weeks | |
| Textiles modified by Ag compounds | |||
|
| |||
| Rehan | Ag NPs/cotton | Blocks UV and inhibits | |
| Xu | Ag NPs/cotton | Inhibits | |
| Emam | Ag NPs/cotton | Inhibits | |
| Li | Ag NPs/cotton | Inhibits | |
| El‐Rafie | Ag NPs/cotton | Inhibits | |
| Zhang | Ag NPs/cotton | Inhibits | |
| Gerba | Ag NPs/cotton | Inhibits salmonella, MRSA, | |
| Balakumaran | Ag NPs/cotton | Inhibits | |
| Dhiman | Ag NPs/cotton | Inhibits | |
| Pulit‐Prociak | Ag NPs/cotton | Inhibits | |
| Shaheen | Ag NPs/cotton | Inhibits | |
| Rodrigues | Ag NPs/cotton and polyester | Inhibits | |
| Ali | Ag NPs/polyester | Inhibits | |
| Noor | Ag NPs/polyviscose | Inhibits | |
| Mofidar | Ag NPs/polyacrylic acid fibers | Inhibits | |
| Rehan | Ag/AgI NPs/viscose | Inhibits | |
| Tremiliosi | Ag NPs/polyester‐cotton | Inhibits | |
| Ibănescu | Ag/ZnO NPs/cotton and cotton‐polyester | Inhibits | |
| Shin | Ag/Ag‐SiO2 NPs/polyester | Inhibits | |
| Nischala | Ag‐SiO2/cotton | Inhibits | |
|
| |||
| Juenger | Padycare (polyamide, Ag NPs/lycra) | Reduced clinical severity of AE and pruritus within a wearing period of 2 weeks | |
| Park | Skin Doctor (TiO2–Ag NPs/algal cellulose) | Reduction in | |
| Araújo | Skin to skin (cotton, Ag NPs/algal cellulose) | Decreases up to 70% of itching. Quality of sleep improved to about 65%. | |
| Fluhr | Ag NPs/algal cellulose | Reduction in | |
| Srour | DermaSilk (AEGIS 5772/silk), Padycare (polyamide, Ag NPs/lycra), SkinProtect (Ag NPs/cotton and polyester), Binamed (modal, Ag NP/polyester, lycra), Platatex (Ag NPs/cotton and polyester), Pulmanova Bioactive (Ag NPs/cotton), Silver‐Skin (AgNPs/cotton and polyester), Best4Body (Ag NPs/cotton), Schiesser (Ag NPs/cotton), Medima Antisept (Ag NPs/cotton and polyamide), Sansita (micromodal, lycra and Ag NPs/cellulose) | Textiles coated by Ag NPs delivered durable antimicrobial activity unaffected by laundering | |
| Hoefer | Ag NPs/polyester | No pathogenic germs occurred in the microflora of the subjects during 4 weeks | |
| Daeschlein | Ag NPs/polyamide | Inhibited | |
| Morand | Ag NPs/polyamide and elastane | Alleviated perineal folliculitis | |
ATIE, antibiotic treatment initiation events; HCAI, health care‐associated infection; MDRO, multidrug‐resistant organisms; MRSA, methicillin‐resistant Staphylococcus aureus; NPs, nanoparticles; TEWL, transepidermal water loss.